Related Experiment Video
Updated: Jun 20, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Pleiotropic effects with equivalent low-density lipoprotein cholesterol reduction: comparative study between
Daniel B Araujo1, Marcelo C Bertolami, Waldinai P Ferreira
1Dyslipidemia Department of Dante Pazzanese, Institute of Cardiology, Sao Paulo, Brazil. dbaraujo@gmail.com
Journal of Cardiovascular Pharmacology
|September 23, 2009
Summary
Simvastatin and ezetimibe coadministration showed similar pleiotropic effects as high-dose simvastatin alone, improving endothelial function and reducing inflammation markers. Both treatments effectively lowered LDL-c levels.
Area of Science:
- Cardiovascular Pharmacology
- Lipid Metabolism Disorders
Background:
- Coadministration of statins with ezetimibe matches high-dose statin efficacy for lowering LDL-cholesterol.
- Potential for additional pleiotropic effects beyond lipid reduction exists.
Purpose of the Study:
- To compare the effects of equivalent LDL-cholesterol-lowering strategies on endothelial function and inflammation.
- Investigated simvastatin (80 mg/day) versus simvastatin (10 mg/day) plus ezetimibe (10 mg/day).
Main Methods:
- A 2x2 crossover study involving 23 hypercholesterolemic patients.
- Endothelial function assessed via flow-mediated vasodilation (brachial artery ultrasound).
- Inflammation measured by high-sensitivity C-reactive protein (hs-CRP).
Main Results:
- Both treatments achieved comparable LDL-cholesterol reduction.
- Significant improvements in endothelial function were observed in both groups, with no significant difference between them.
- A notable reduction in hs-CRP levels was seen with both simvastatin/ezetimibe and simvastatin alone, without significant inter-group differences.
Conclusions:
- The combination of simvastatin and ezetimibe demonstrated similar pleiotropic effects to high-dose simvastatin.
- Both therapeutic approaches effectively improved endothelial function and reduced hs-CRP levels.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:24Lipid Absorption
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:18Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...